Personalized Medicine Bulletin

Latest from Personalized Medicine Bulletin

Does payer coverage of genomic testing drive utilization? That is the question The Personalized Medicine Coalition (“PMC”) asked and answered in its recent report “Understanding Genomic Testing Utilization and Coverage in the US” (“Study”). PMC’s Study, conducted in
Continue Reading Does Payer Coverage Drive Genomic Test Utilization in the United States?

On December 12, 2019, an outbreak of a severe pneumonia broke out of Wuhan, China.  The causative agent of the outbreak was determined to be a coronavirus, an enveloped positive- and single-stranded RNA virus that infects vertebrates.  The newly discovered
Continue Reading Coronavirus Innovation Guideposts on the Eve of the COVID-19 Pandemic

Personalized medicine selects the best therapy or course of treatment for each patient based on diagnostic testing. In one aspect, personalized medicine uses pharmacogenetic testing to provide information regarding: 1) how an individual’s genes affect that person’s response to medications;
Continue Reading Collaborative Review of Scientific Evidence Announced By FDA

Personalized medicine selects the best therapy or course of treatment for each patient based on diagnostic testing. In one aspect, personalized medicine uses pharmacogenetic testing to provide information regarding: 1) how an individual’s genes affect that person’s response to medications;
Continue Reading Collaborative Review of Scientific Evidence Announced By FDA